Emerging Agents in the Pipeline for Merkel Cell Carcinoma
2 Pogledi
administrator
07/17/23
Howard L. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, discusses emerging agents in the pipeline for Merkel cell carcinoma.
Prikaži više
Komentari na Facebooku
Nema komentara